Microba Life Sciences LimitedASX: MAP

Microba secures $2m placement and increases cost reductions

· Issued by Microba Life Sciences Limited via ASX

Filed with ASX · · 4 pages · English

Summary by 6ix AI

Microba Life Sciences Limited has announced a placement to raise funds and implement cost reductions. The company secured commitments for a significant amount through a two-tranche placement to support its financial position and ongoing merger discussions. Additionally, Microba is reducing its annual operating costs and exploring the sale of its Invivo Supplements business. The filing also includes updates on leadership changes and trading performance for the first quarter of the fiscal year.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX Announcement 20 October 2026 Microba secures $2.025 million placement and increases cost reduction programme Microba Life Sciences Limited (ASX: MAP) (Microba or the Company) announces that it has received firm commitments to raise $2.025 million (before costs) through a two-tranche placement...

Microba Life Sciences Limited on 6ix

Story so far

Earlier from Microba Life Sciences

Later from Microba Life Sciences

All Microba Life Sciences news releases